Tenex Health Appoints Doug Kohrs as Executive Chairman of the Board

LAKE FOREST, Calif., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Tenex Health
today announced that Doug Kohrs, a current member of the Board of
Directors, will assume the role of Executive Chairman effective
immediately. Board Member Tommy Thompson, former governor of Wisconsin
and former Secretary of the United States Department of Health and
Human Services said of Kohrs' appointment, "The company has
successfully proven the clinical and commercial strength of the TX
System. As we focus on broader market expansion, Doug's extensive
experience as a medical device CEO will provide significant benefit to
customers, employees, and shareholders."

Mr. Kohrs brings significant operating experience to his new role as
Executive Chairman at Tenex Health. He has over 30 years experience in
the medical device industry and has spent 15 of those years as a chief
executive of public and private companies. Doug has formerly served as
CEO of Tornier, CEO of American Medical Systems, and was a founding
member of Spine-Tech. Over his successful career in medical devices he
has also served on the Board of Directors of fifteen different medical
device companies.

Doug Kohrs commented, "I am excited to serve in this role and help the
company fully optimize the commercial and clinical opportunities that
reside within this ground-breaking technology. I look forward to a
bright future for Tenex Health."

Current Board Chairman Ivan Mijatovic will remain on the Board of
Directors. In addition, Ivan will assume the role of Chief Financial
Officer on an interim basis and will oversee the search for a permanent
CFO.

About Tenex Health, Inc.

Tenex Health, Inc. (www.tenexhealth.com) (www.tenexhealthpatient.com)
develops and markets innovative therapies for the treatment of tendon
pain due to trauma or repetitive motion injuries. The minimally
invasive technique utilizes the company's proprietary TX MicroTip(TM)
handpiece to cut and debride diseased tissue in an outpatient setting
in under 20 minutes, using only a local anesthetic. Since the
surrounding healthy tendon tissue is not disturbed, patients enjoy less
discomfort and faster recovery times versus traditional open surgical
procedures.


CONTACT: Tenex Health, Inc.
         MaryAnn Tingley
         Vice-President of Marketing
         949-454-7500 x 245

Suggested Articles

The ambitious target is enabled by an AI discovery platform that Healx thinks gives it a scalability that has more in common with tech than biotech.

Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations.

After being hailed as a near mystic when it came to stock picks, Britain’s once great oak has been cut down to a sapling as Neil Woodford gets the ax.